TABLE 3.
Serum SSC5D levels were highly associated with the risk factors of HF.
| Unadjusted | p-Value | Model 1 | p-Value | Model 2 | p-Value | |
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| logSSC5D (per SD) | 3.23 (2.32–4.50) | <0.001 | 3.60 (2.53–5.11) | <0.001 | 3.40 (2.10–5.51) | <0.001 |
| SSC5D tertiles | 3.31 (2.35–4.66) | <0.001 | 4.16 (2.77–6.26) | <0.001 | 3.41 (2.05–5.67) | <0.001 |
| Tertile 1 | 1 (referent) | 1 (referent) | 1 (referent) | |||
| Tertile 2 | 3.61 (1.87–6.97) | <0.001 | 4.90 (2.38–10.10) | <0.001 | 4.03 (1.71–9.48) | 0.001 |
| Tertile 3 | 11.02 (5.53–21.97) | <0.001 | 17.70 (7.78–40.24) | <0.001 | 11.83 (4.30–33.09) | <0.001 |
SSC5D concentration was normalized by log10 transformation to obtain normality and divided into tertiles.
Model 1: Adjusted for age and sex.
Model 2: Adjusted for sex, age, BMI, diabetes mellitus, hypercholesterolemia, hypertension, hemoglobin, creatinine, low-density lipoprotein cholesterol, hypersensitive C-reactive protein, blood urea nitrogen, HbA1c, and estimated glomerular filtration rate.